Evidence map›Paper›PMID 32676895›Full record

Observational studyClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2021

Impact of adjuvant therapy toxicity on quality of life and emotional symptoms in patients with colon cancer: a latent class analysis.

D Gomez, C Calderón, A Carmona-Bayonas, D Cacho Lavin, M M Muñoz, R Martinez Cabañez, P Jimenez-Fonseca

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  2. Trial
  3. Narrative medicine in patients with cancer during intravenous antiblastic therapy: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  4. Article
  5. Review
  6. Article
  7. Quality of life outcomes in colorectal cancer survivors: insights from an observational study at a tertiary cancer center.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Observational
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

D GomezDepartment of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, University of Pais Vasco, Pais Vasco, Avenida Roma sn, 33011, Oviedo, Spain.
C CalderónDepartment of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, University of Pais Vasco, Pais Vasco, Barcelona, Spain.
A Carmona-BayonasDepartment of Medical Oncology, Hospital Universitario Morales Meseguer, UMU, IMI, Murcia, Spain.
D Cacho LavinDepartment of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
M M MuñozDepartment of Medical Oncology, Hospital Universitario Virgen de La Luz, Cuenca, Spain.
R Martinez CabañezDepartment of Medical Oncology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
P Jimenez-FonsecaDepartment of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, University of Pais Vasco, Pais Vasco, Avenida Roma sn, 33011, Oviedo, Spain. palucaji@hotmail.com.ORCID http://orcid.org/0000-0003-4592-3813
Hospital Universitario Central de Asturias · ESHospital General Universitario Morales Meseguer · ESHospital Universitario Fundación Alcorcón · ESHospital Virgen de la Luz · ESInstituto de Investigación Marqués de Valdecilla · ESUniversitat de Barcelona · ES

Funding

Sociedad Española de Oncología Médica FSEOM-Onvida for Projects on Long Survivors and Quality of Life. SEOM (Spanish Society of Medical Oncology) 2015
6 · The paper itself

Abstract

objectiveTo identify distinct trajectories of toxicity in colorectal cancer (CRC) patients after adjuvant chemotherapy and its impact on quality of life (QoL) and psychological symptoms.

methodsA prospective, multicenter study was conducted in 157 patients. A latent class analysis defined the unobserved latent constructs that can be predicted as symptom clusters, considering the intensity of four types of adverse events (AEs). Patients completed EORTC-QLQ-C30, BSI-18, PDRQ-9, and DRS scales.

resultsNinety-six percent had some degree of toxicity, with grades 3-4 being the most common: neurotoxicity (7.2%), hematological (13.1%), digestive (5.2%), and skin toxicity (1.4%). Three distinct latent classes were identified (high [72.5%], mild [16.9%], and low [10.6%] toxicity). Patients with high toxicity had the worst QoL scores and moderately high somatization and psychological distress scores.

conclusionsAdjuvant chemotherapy for CRC was associated with frequent toxicity that negatively impacted QoL and psychological wellbeing.

Indexed as

Latent Class AnalysisQuality of LifeAgedAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsCapecitabineChemotherapy, AdjuvantColonic NeoplasmsDecision MakingEmotionsFemaleFluorouracilHumansLeucovorinMaleMiddle AgedAntimetabolites, AntineoplasticCapecitabineFluorouracilLeucovorinOrganoplatinum CompoundsoxiplatinPyridinesAdjuvant treatmentCancerLatent class analysisOxaliplatinToxicityTrajectory analysis

Identifiers

PMID32676895
OpenAlexW3043331254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.